🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EsophaCap for the Detection of Early Esophageal Carcinoma

Recruitingn/aAges 18 Years - anyAllJohns Hopkins University
NCT04214119 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is to identify potential biomarkers for the early detection of Barrett's Esophagus, esophageal carcinoma (both adenocarcinoma and squamous cell carcinoma), and gastric cancer via sponge cytology.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Undergoing esophagogastroduodenoscopy at Johns Hopkins Hospital from 1/2016 to 12/2025 * Age greater than 18 years * Patients must be able to swallow a capsule Exclusion Criteria: * Patients in either arm with extra-esophageal malignancies including head and neck and gastric cancer * Patients who have undergone esophagectomy * Patients who have undergone radiation to the chest * Patients who are younger than 18 * Patients with esophageal stents * Patients with esophageal strictures disabling passage of the capsule
💊

What it tests

  • Not listed
📍

Where

2 sites
Bayview Medical Center
Baltimore, United States
Johns Hopkins Hospital
Baltimore, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy